12/10/2025
Safe and effective treatments for Alzheimer’s are urgently needed — and you can help make a difference. Researchers at the KU Alzheimer’s Disease Research Center are studying whether a new investigational drug, VHB937, could help slow early symptoms of Alzheimer’s disease.
✅ Adults ages 50–85 years old are eligible to participate
✅ Only available to adults diagnosed with Mild Cognitive Impairment (MCI) or dementia due to Alzheimer’s disease
Take part in advancing research that could bring hope to countless families affected by Alzheimer’s!
Please visit kuadrc.org/novartis to learn more and see if you qualify!